Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

Investing in high-yield dividend stocks can provide stable passive income in retirement with our 8% yielding model portfolio.

Learn about CSHI, an ETF that invests in T-bills and S&P 500 option spreads for increased yields and income. Learn more about ...

UTG has recovered most losses since 2023, but its valuation remains high. Click here to read why I am neutral on UTG CEF.

Mercer International's (MERC) valuation metrics indicate it may be undervalued at its current share price, therefore I ...

Workiva's strong fundamentals include consistent mid-teens growth, improving net retention rates, and mission-critical ...

AMC Entertainment shifted $2.4 billion in 2026 debt maturities to 2029 and 2030. Click here to read why I have upgraded AMC ...

My strategy aims for a $50,000 annual income portfolio by age 40. Check out my Top 3 largest holdings that comprise just ...

JRI increased its distribution by over 33% to narrow its discount and fend off activists. Read why JRI CEF has been ...

IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...

Commonwealth Bank of Australia's ROE and dividend payout ratios were better than its key Australian banking peers. Read why I ...

Caterpillar has a profitable growth strategy, including expanded offerings and services. Read why I have upgraded CAT stock ...